Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[EM]

SHARE STRUCTURE UDPATE
https://www.sec.gov/Archives/edgar/data/1614744/000121390017011510/f6k110717_kitovpharma.htm

As of November 6, 2017:
(1) Ordinary Shares 224,192,013
(2) Kitov Nasdaq Listed “Series A” Warrants 6,835,669
(3) Series 7/14 options 600,000
(4) Kitov Underwriter Warrants (11/2015) 157,945
(5) 2016 Equity-Based Incentive Plan – Options and RSUs 23,685,215
(6) Kitov Placement Agent Warrants (7/2016) 141,176
(7) Kitov Investor Warrants (7/2017) 1,215,873
(8) Kitov Placement Agent Warrants (7/2017) 170,222

(1) 21 of such Ordinary Shares are dormant shares held in treasury. The 224,192,013 issued and outstanding Ordinary Shares would be represented by 11,209,600.60 of our American Depositary Shares (ADSs), as each of our ADSs represents 20 of our Ordinary Shares.
(2) Each NASDAQ Listed “Series A” Warrant is exercisable into one ADS of the Company. The aggregate number of ADSs into which the issued and outstanding Kitov NASDAQ Listed “Series A” Warrants could be exercised is 6,835,669, which would represent 136,713,380 of our Ordinary Shares.
(3) Each Series 7/14 option is exercisable into 0.07692 Ordinary Shares of the Company. The aggregate number of Ordinary Shares into which the issued and outstanding Series 7/14 options could be exercised is 46,152. Such number of Ordinary Shares would be represented by 2,307.6 of our ADSs.
(4) Each Kitov Underwriter Warrant (11/2015) is exercisable into one ADS of the Company. The aggregate number of ADSs into which the issued and outstanding Kitov Underwriter Warrants (11/2015) could be exercised is 157,945, which would represent 3,158,900 of our Ordinary Shares.
(5) Each of the outstanding Options or Restricted Share Units (“RSU”) which were issued by us pursuant to our 2016 Equity-Based Incentive Plan is exercisable into one Ordinary Share of the Company. The 23,685,215 Ordinary Shares into which the issued and outstanding Options and RSUs could be exercised would be represented by 1,184,260.75 of our ADSs.
(6) Each Kitov Placement Agent Warrant (7/2016) is exercisable into one ADS of the Company. The aggregate number of ADSs into which the issued and outstanding Kitov Placement Agent Warrants (7/2016) could be exercised is 141,176, which would represent 2,823,520 of our Ordinary Shares.
(7) Each Kitov Investor Warrant (7/2017) is exercisable into one ADS of the Company. The aggregate number of ADSs into which the issued and outstanding Kitov Investor Warrants (7/2017) could be exercised is 1,215,873, which would represent 24,317,460 of our Ordinary Shares.
(8) Each Kitov Placement Agent Warrant (7/2017) is exercisable into one ADS of the Company. The aggregate number of ADSs into which the issued and outstanding Kitov Placement Agent Warrants (7/2017) could be exercised is 170,222, which would represent 3,404,440 of our Ordinary Shares.

FLOAT (ADSs): 11.209.600
FULLY DILUTED CAPITAL (ADSs): 20.917.054

If series A warrants (2) exercised Kitov should receive $25.838.828,82; If Investor Warrants (7) exercised Kitov should receive $4.596.000.

Current (as per November 13 close) Market Cap fully diluted: $ 43.298.301,78